AP2B1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.074400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.689500E-02
Normal-vs-Stage2
3.302600E-01
Normal-vs-Stage3
9.834800E-01
Normal-vs-Stage4
4.936100E-02
Stage1-vs-Stage2
8.064200E-01
Stage1-vs-Stage3
2.015400E-01
Stage1-vs-Stage4
5.900200E-01
Stage2-vs-Stage3
2.764400E-01
Stage2-vs-Stage4
5.713400E-01
Stage3-vs-Stage4
1.704210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.175600E-01
Normal-vs-AfricanAmerican
3.493000E-01
Normal-vs-Asian
4.817000E-01
Caucasian-vs-AfricanAmerican
6.024800E-01
Caucasian-vs-Asian
6.471000E-01
AfricanAmerican-vs-Asian
5.311200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.418800E-01
Normal-vs-Female
2.816200E-01
Male-vs-Female
2.063400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.814220E-01
Normal-vs-Age(41-60Yrs)
1.340420E-01
Normal-vs-Age(61-80Yrs)
4.697400E-01
Normal-vs-Age(81-100Yrs)
3.265200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.703600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.821400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.889200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.979300E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.786000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.187600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.507400E-01
Normal-vs-Daily Drinker
5.361000E-01
Normal-vs-Weekly Drinker
4.706600E-01
Normal-vs-Occasional Drinker
2.157400E-01
Normal-vs-Social Drinker
1.735950E-01
Non Drinker-vs-Daily Drinker
7.740600E-01
Non Drinker-vs-Weekly Drinker
6.835200E-01
Non Drinker-vs-Occasional Drinker
2.295500E-02
Non Drinker-vs-Social Drinker
2.293800E-02
Daily Drinker-vs-Weekly Drinker
8.748400E-01
Daily Drinker-vs-Occasional Drinker
3.340400E-02
Daily Drinker-vs-Social Drinker
4.746300E-02
Weekly Drinker-vs-Occasional Drinker
4.691900E-02
Weekly Drinker-vs-Social Drinker
1.028820E-01
Occasional Drinker-vs-Social Drinker
5.153800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.096200E-02
Normal-vs-Grade 2
1.543840E-02
Normal-vs-Grade 3
2.480500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.772800E-01
Grade 1-vs-Grade 3
5.021200E-01
Grade 1-vs-Grade 4
7.096200E-02
Grade 2-vs-Grade 3
7.927600E-01
Grade 2-vs-Grade 4
1.543840E-02
Grade 3-vs-Grade 4
2.480500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.150200E-01
Normal-vs-NonDiabetic
2.130200E-01
Diabetic-vs-NonDiabetic
2.864600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.080300E-02
Normal-vs-NoPancreatitis
3.449800E-01
Pancreatitis-vs-NoPancreatitis
1.849210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.661200E-01
Normal-vs-N1
3.276400E-01
N0-vs-N1
8.164600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.161200E-01
Normal-vs-TP53-NonMutant
6.619000E-01
TP53-Mutant-vs-TP53-NonMutant
3.316300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
